Menu

Image of the Day: Un-break My Heart

A failing heart is easily distinguished from a healthy one by numerous tell-tale signs, including its slender, stretched-out walls, increased size, and pooled blood clots.

Aug 8, 2017
The Scientist Staff

Healthy (left) and failing (right) mouse hearts. A blood clot noticeably pools in the top right chamber of the failing heart.GRUETER LABORATORY, UNIVERSITY OF IOWA HEALTH CARE Researchers recently unearthed gene expression patterns in heart tissues from a mouse model of heart failure that were noticeable before the mice’s hearts began to show symptoms. These patterns mimicked those observed in diseased human heart cells.

“In terms of disease progression, heart failure is the end stage,” says senior author Chad Grueterin a news release. “Our study suggests that the transition, or ‘switch,’ from a stressed, enlarged heart to a failing heart is key. Looking ahead, hopefully we’ll be able to test whether a drug can block that switch from occurring.”

See D.D. Hall et al., “Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure,” JCI Insight2:e92476, 2017.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.